← Leaderboards
Corey S Cutler
Beth Israel Deaconess Medical Center
$6,266,747
Attributed
$7,797,962
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,276,495 · 8
By mechanism
P01$23,214,064 · 7
R01$3,062,431 · 1
Top collaborators
- Vassiliki A Boussiotis5 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Vassiliki A Boussiotis$19,288,605
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsChronicClinical TrialsMouse ModelImmunologicsAllogenicMonitorCellsPathway InteractionsRegulatory T-LymphocyteResponseGenerationsBaseIncidenceSignal TransductionT-LymphocyteAffectIn VivoMorbidity - Disease RateTransplantationImmuneSafetyFunctional DisorderHelper-Inducer T-Lymphocyte
Grant awards (32)
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease$2,563,941
P01 · FY2025 · HL · contact PI
Bronchiolitis Obliterans: Discovery and Therapy$647,464
P01 · FY2025 · HL · contact PI
Admin Core$49,805
P01 · FY2025 · HL · contact PI
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease$2,508,066
P01 · FY2024 · HL · contact PI
Bronchiolitis Obliterans: Discovery and Therapy$636,798
P01 · FY2024 · HL · contact PI
Admin Core$48,611
P01 · FY2024 · HL · contact PI
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease$2,583,098
P01 · FY2023 · HL · contact PI
Bronchiolitis Obliterans: Discovery and Therapy$663,454
P01 · FY2023 · HL · contact PI
Admin Core$49,816
P01 · FY2023 · HL · contact PI
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease$2,665,095
P01 · FY2022 · HL · contact PI
Bronchiolitis Obliterans: Discovery and Therapy$673,610
P01 · FY2022 · HL · contact PI
Admin Core$51,167
P01 · FY2022 · HL · contact PI
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease$1,581,533
P01 · FY2019 · CA · contact PI
Project 1: Targeting B Cells in Chronic Graft-vs.Host Disease Prevention and Treatment$244,472
P01 · FY2019 · CA · contact PI
Core A: Administrative Core$125,955
P01 · FY2019 · CA · contact PI
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease$1,630,446
P01 · FY2018 · CA · contact PI
Project 1: Targeting B Cells in Chronic Graft-vs.Host Disease Prevention and Treatment$250,586
P01 · FY2018 · CA · contact PI
Core A: Administrative Core$132,070
P01 · FY2018 · CA · contact PI
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease$1,630,446
P01 · FY2017 · CA · contact PI
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT$894,037
R01 · FY2017 · CA
Project 1: Targeting B Cells in Chronic Graft-vs.Host Disease Prevention and Treatment$250,586
P01 · FY2017 · CA · contact PI
Core A: Administrative Core$132,070
P01 · FY2017 · CA · contact PI
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease$1,630,446
P01 · FY2016 · CA · contact PI
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT$536,875
R01 · FY2016 · CA
Project 1: Targeting B Cells in Chronic Graft-vs.Host Disease Prevention and Treatment$250,586
P01 · FY2016 · CA · contact PI
Core A: Administrative Core$132,070
P01 · FY2016 · CA · contact PI
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease$1,685,462
P01 · FY2015 · CA · contact PI
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT$536,875
R01 · FY2015 · CA
Project 1: Targeting B Cells in Chronic Graft-vs.Host Disease Prevention and Treatment$257,463
P01 · FY2015 · CA · contact PI
Core A: Administrative Core$138,948
P01 · FY2015 · CA · contact PI
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT$520,769
R01 · FY2014 · CA
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT$573,875
R01 · FY2013 · CA